Social Media and Communication Co-ordinator || Former Product Management Intern at Bioceutics Inc. || MBA - Pharmaceutical Management '25 || NIPER Hyderabad ||
|| Pharma Fusion Series 1.8 || 🌟 Vertex Pharmaceuticals's Mega $4.9B Deal with Alpine Immune Sciences, Inc. Signals Immunotherapy Surge 💼💥🚀 Vertex Pharmaceuticals has acquired Alpine Immune Sciences, Inc., for $4.9 billion. This strategic move aims to accelerate the development and potential commercialization of povetacicept, a promising treatment for IgA nephropathy and other serious autoimmune diseases. 💼💡 The acquisition enhances Vertex's capabilities with Alpine's expertise in protein engineering and immunotherapy, signaling a notable advancement in protein-based immunotherapies. This acquisition has the potential to significantly impact the future of immunotherapy and the treatment of serious autoimmune conditions, ultimately benefiting patients in need. 🌟🩺 #PharmaceuticalInnovation #VertexPharmaceuticals #AlpineImmuneSciences #IgANephropathy #AutoimmuneDisease #ImmunoTherapy #acquisition #merger #pharmanews #information #povetaciept #proteinengineering #niper #dopm #pharmamba #pharmaprofessionals #FiercePharma ##reuterseventspharma #Reuters
Very informative Debarshi Ghosh ✨👍
Business Development Intern at Remedo ||MBA Pharmaceutical Management, NIPER Hyderabad || NIPER 2023 AIR 230 || GPAT 2023 AIR 1266 || B.Pharm
4moVery useful Debarshi Ghosh ✨